ClinicalTrials.gg
Not yet recruitingNCT07789756USG-SPINEUpdated Aug 27, 2026

Ultrasound Versus Palpation for Determining Spinal Puncture Level in Cesarean Section

An interventional study of Preprocedural ultrasound level identification and Landmark palpation level identification in Cesarean Section (MeSH: D002585), Anesthesia, Spinal (MeSH: D000775) and Hypotension (MeSH: D007022), sponsored by Kahramanmaras Sutcu Imam University. Not yet recruiting at 2 sites in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-27.

Sponsored by Kahramanmaras Sutcu Imam University · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This study compares two methods of identifying the correct intervertebral level before performing spinal anesthesia in women undergoing elective cesarean delivery.

In current practice, anesthesiologists locate the puncture site by feeling anatomical landmarks on the lower back (palpation of Tuffier's line). Ultrasound imaging offers an alternative in which the spine is scanned and the intended level is marked on the skin before the needle is inserted. It is not yet clear whether this additional step improves the success of the procedure or affects the mother's blood pressure and heart rate after the block.

Sixty pregnant women scheduled for elective cesarean section will be randomly assigned to one of two groups. In one group, the puncture level will be determined by preprocedural ultrasound marking; in the other, by conventional landmark palpation. All other aspects of anesthetic care, including drug doses, will be identical in both groups.

The main outcome is the proportion of patients in whom the subarachnoid space is entered successfully at the first attempt with a single skin puncture, producing a block adequate for surgery. Additional outcomes include the number of needle passes, procedure duration, changes in maternal blood pressure and heart rate, vasopressor requirement, sensory block level, and complications such as headache or back pain within 24 hours after surgery.

Read the detailed description

Detailed Description - teknik açıklama, 32.000 karakter sınırı var. Brief Summary'de olmayan yöntem detayları buraya girer. Metin:

Background and Rationale

Spinal anesthesia is the technique of choice for elective cesarean delivery. The intended puncture site is conventionally identified by palpating Tuffier's line, an imaginary line joining the iliac crests, which is assumed to cross the L4 vertebral body or the L4-L5 interspace. Anatomical studies and imaging data have shown that this assumption is unreliable, particularly in pregnancy, where lumbar lordosis, soft tissue changes and altered pelvic tilt shift the landmark cephalad in a substantial proportion of women. Levels selected by palpation are therefore frequently one or more interspaces higher than intended.

Preprocedural ultrasound allows direct visualization of the sacrum and the lumbar interlaminar spaces, and the selected level can be marked on the skin before needle insertion. Whether the improvement in level accuracy translates into clinically meaningful differences in technical success and maternal hemodynamic response has not been established consistently in the obstetric population.

Study Design

This is a prospective, randomized, controlled, parallel-group, single-center trial conducted at the Department of Anesthesiology and Reanimation, Kahramanmaraş Sütçü İmam University Health Practice and Research Hospital.

Sixty ASA II-III women aged 18-45 years with singleton pregnancies scheduled for elective cesarean section under spinal anesthesia will be enrolled after written informed consent. Randomization will be performed using computer-generated block randomization with an allocation ratio of 1:1 (30 per group).

Interventions

Ultrasound group: Before the procedure, the lumbar spine will be scanned with a low-frequency curvilinear probe in the patient's sitting position. The sacrum will be identified in the paramedian sagittal oblique plane and interspaces counted cephalad. The target interspace will be marked on the skin, and the transverse midline plane will be used to confirm the midline. Spinal anesthesia will then be performed at the marked level.

Palpation group: The puncture level will be determined by palpation of Tuffier's line according to standard clinical practice, without ultrasound assistance.

In both groups, spinal anesthesia will be performed with the patient seated, using a midline approach and a pencil-point spinal needle. Hyperbaric bupivacaine with fentanyl will be administered as a single dose, calculated according to the Harten table based on maternal height. A maximum of three puncture attempts is permitted; if unsuccessful, the case will be managed at the discretion of the attending anesthesiologist and recorded as a failure of the allocated technique.

After completion of the block, and without any modification of clinical management, ultrasonography will be used in both groups purely for observational purposes to verify the intervertebral level at which the dural puncture was performed. This exploratory assessment allows quantification of level accuracy in both arms.

Measurements

Baseline maternal characteristics (age, height, weight, body mass index, gestational age, ASA class, parity) will be recorded. Procedure-related variables include the number of skin punctures, number of needle redirections, and procedure duration measured from needle-skin contact to visualization of cerebrospinal fluid.

Non-invasive blood pressure and heart rate will be recorded at baseline and every 3 minutes thereafter until delivery and subsequently until the end of surgery. Hypotension is defined as a mean arterial pressure below 65 mmHg or a decrease of 20% or more from the baseline value, and will be treated with intravenous ephedrine according to institutional protocol; total ephedrine dose will be recorded.

Sensory block level will be assessed bilaterally at 10 and 15 minutes after intrathecal injection. Intraoperative nausea and vomiting, paresthesia during needle insertion, bloody tap, incomplete block, requirement for supplemental analgesia, and conversion to general anesthesia will be documented. Patients will be assessed at 24 hours postoperatively for post-dural puncture headache, back pain, and satisfaction using a visual analogue scale.

Sample Size

The sample size was calculated using G*Power 3.1, based on success rates reported by Li et al. (2019). For the comparison of proportions between two independent groups using Fisher's exact test, with a significance level of 0.05, power of 0.80, and an effect size of h = 0.79, a minimum of 30 participants per group is required, giving a total of 60 participants.

Statistical Analysis

Distribution of continuous variables will be assessed with the Shapiro-Wilk test and visual methods. Normally distributed data will be presented as mean ± standard deviation and non-normally distributed data as median with interquartile range. Between-group comparisons will use the independent samples t-test or Mann-Whitney U test for continuous variables, and the chi-square or Fisher's exact test for categorical variables. Changes in hemodynamic parameters over time will be analyzed using repeated measures analysis (mixed model or repeated measures ANOVA, according to assumption checks). Statistical significance will be accepted at p \< 0.05. Analyses will primarily follow the intention-to-treat principle, and missing data will be reported.

02

Conditions studied

  • Cesarean Section (MeSH: D002585)
  • Anesthesia, Spinal (MeSH: D000775)
  • Hypotension (MeSH: D007022)

Browse trials for

Keywords

  • preprocedural ultrasound
  • neuraxial anesthesia
  • Tuffier's line
  • landmark palpation
  • obstetric anesthesia
  • first-attempt success
03

In context

Hypotension

885 studies on the registry are indexed under Hypotension; 195 are open to participants now.

This study's planned enrollment of 66 is below the median of 87 across 590 interventional studies indexed under Hypotension.

Browse Hypotension studies →

Lead sponsor

Kahramanmaras Sutcu Imam University is the lead sponsor of 198 studies on the registry; 40 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Scheduled for elective cesarean section under spinal anesthesia
  • Age 18 to 45 years
  • II or III
  • Singleton pregnancy
  • No to spinal anesthesia
  • Normotensive
  • Provides written

Exclusion criteria

Exclusion Criteria:

  • Emergency cesarean section
  • Morbid obesity ( 40 kg/m² or higher)
  • History of lumbar spine surgery
  • Severe spinal deformity
  • Local infection at the puncture site
  • Coagulopathy or ongoing anticoagulant therapy
  • Anatomical abnormality expected to require multiple puncture attempts
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
66 participants (estimated)

Study arms

  • Experimental
    Ultrasound Group

    Preprocedural ultrasound scanning of the lumbar spine in the sitting position with a low-frequency curvilinear probe. The sacrum is identified in the paramedian sagittal oblique plane, interspaces are counted cephalad, and the target interspace is marked on the skin. Spinal anesthesia is then performed at the marked level.

    Procedure: Preprocedural ultrasound level identification

  • Active comparator
    Palpation Group

    Puncture level determined by palpation of Tuffier's line according to standard clinical practice, without ultrasound assistance. Spinal anesthesia is performed at the palpated level.

    Procedure: Landmark palpation level identification

Interventions

  • ProcedurePreprocedural ultrasound level identification

    Ultrasound-assisted identification and skin marking of the target intervertebral level before spinal needle insertion. Spinal anesthesia is performed with the patient seated, using a midline approach and a pencil-point spinal needle, with hyperbaric bupivacaine and fentanyl dosed according to the Harten table based on maternal height. A maximum of three puncture attempts is permitted.

  • ProcedureLandmark palpation level identification

    Identification of the target intervertebral level by palpation of Tuffier's line. Spinal anesthesia is performed with the patient seated, using a midline approach and a pencil-point spinal needle, with hyperbaric bupivacaine and fentanyl dosed according to the Harten table based on maternal height. A maximum of three puncture attempts is permitted.

06

What researchers measure

Primary outcomes

  1. First-attempt success rate

    Successful dural puncture (CSF flow) with a single skin puncture at the selected level, with adequate surgical block and no need for supplemental analgesia or GA.

    Time frame: During spinal procedure (up to 30 minutes)

Secondary outcomes

  1. Number of skin punctures and needle redirections

    Number of skin punctures and number of needle redirections required to achieve dural puncture

    Time frame: During the spinal procedure, up to 30 minutes

  2. Procedure duration

    Time from needle-skin contact to visualization of cerebrospinal fluid

    Time frame: During the spinal procedure, up to 30 minutes

  3. Incidence of hypotension

    Mean arterial pressure below 65 mmHg or a decrease of 20% or more from baseline

    Time frame: From intrathecal injection to end of surgery, up to 90 minutes

  4. Total ephedrine dose

    Time frame: From intrathecal injection to end of surgery, up to 90 minutes

  5. Sensory block level

    Assessed bilaterally by pinprick

    Time frame: 10 and 15 minutes after intrathecal injection

  6. Incidence of nausea and vomiting

    Time frame: Intraoperative period, up to 90 minutes

  7. Incidence of paresthesia during needle insertion

    Time frame: During the spinal procedure, up to 30 minutes

  8. Incidence of bloody tap

    Time frame: During the spinal procedure, up to 30 minutes

  9. Incidence of incomplete block requiring supplemental analgesia or conversion to general anesthesia

    Time frame: Intraoperative period, up to 90 minutes

  10. Incidence of post-dural puncture headache

    Time frame: Within 24 hours after surgery

07

Study locations

2 sites
  • Kahramanmaraş Sütçü İmam University Health Practice and Research Hospital
    Kahramanmaraş, Onikişubat 46040, Turkey (Türkiye)
    • Feyza Çalışır · Contactfbolcal@hotmail.com · 05056492875
    • Feyza Çalışır, MD · Contactfbolcal@hotmail.com
    • Feyza Çalışır, MD · Principal investigator
    • Betül Bağrıaçık, MD · Sub investigator
    • Selim Karaküçük, MD · Sub investigator
  • Kahramanmaraş Sütçü İmam University Health Practice and Research Hospital
    Kahramanmaraş, Onikişubat 46100, Turkey (Türkiye)
    • Feyza Çalışır, MD · Contactfbolcal@hotmail.com · 05056492875
    • Betül Bağrıaçık, MD · Sub investigator
    • Selim Karaküçük, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be made publicly available. De-identified data supporting the published results may be provided by the corresponding author upon reasonable request, subject to approval by the institutional ethics committee and in accordance with national data protection legislation.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07789756
Responsible party
Feyza Calisir (Associate Professor Dr, Kahramanmaras Sutcu Imam University) — Principal investigator
First posted
Aug 27, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Sep 2027 (estimated)
Completion
Sep 2027 (estimated)
Last update
Aug 27, 2026

Study contacts

Feyza Çalışır, MD
Contact
fbolcal@hotmail.com
+905056492875
Betül Bağrıaçık, MD
Contact
fbolcal@hotmail.com
Feyza Çalışır
principal investigator · Kahramanmaras Sutcu Imam University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion